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Abstract
Cardiovascular diseases (CVD) are the most common cause of death worldwide. 
As arterial as venous thrombosis are major cause’s morbidity and mortality. There 
is an exponential increase in the risk of arterial and venous thrombotic events with 
age, gender, smoking habits, diet type etc. The association of arterial and venous 
thrombosis and ABO histo-blood group is well established. Our research aim was 
to find a possible relationship between age, gender, smoking habit, ABO, Rh, Kell, 
MN blood group and arterial thrombosis in the example of the Georgian popula-
tion. The study material comprised the blood samples of 100 patients with arterial 
thrombosis. Also, control (donor) groups were studied. The Control group included 
individuals without cardiovascular disease during the 2019–2020 periods. They 
were asymptomatic, healthy persons. The immunoserological express method with 
universal monoclonal antibodies ware used. 77% of the studied patients were males. 
The majority of patients were over the 60 years old. 35% of our studied patients are 
non-smoker, 39% are ex-smoker, and 26% are active smokers. A similar distribution 
has the ABO and Rh phenotypes in patients and donors. M+ N+ (MN) the phe-
notype is relatively high in the patient group to comparing to donors. Kell antigen 
prevalence was relatively high in studied patients. Our study has shown maleness 
as a higher risk factor for arterial thrombosis. The smokers have a more predicted 
chance for arterial thrombosis. K+ phenotype and M+ N+ characteristics are a high 
prevalence in patients. There is no correlation between ABO and Rh blood groups 
with arterial thrombosis.
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1. Introduction
Cardiovascular diseases (CVD) are the most common causes of death world-
wide. As already well known, the CVD has several risk factors such as blood pres-
sure, glucose, lipids, blood pressure, glucose, lipids, blood pressure glucose, lipids 
etc. As arterial as venous thrombosis are major cause’s morbidity and mortality. 
Erythrocyte - A Peripheral Biomarker for Viral and Bacterial Infections
2
There is an exponential increase in the risk of arterial and venous thrombotic events 
with age, gender, smoking habits, diet type, etc. [1]
The reason of arterial thrombosis (AT) is rupture of atherosclerotic plaque and 
formation of platelet-mediated thrombi, which can cause ischemic injuries. The 
clinical manifestations of atherothrombosis in most cases are cardiac ischemia and 
stroke. After the acute Myocardial Infarction (MI) and stroke, venous thrombosis 
(VT) is most common vascular disease. Venous thrombi are produced by fibrin and 
red blood cells. VT and AT are associated with variety of causes. For example, VT is 
associated with hypercoagulatin or reduced blood flow, while AT has been linked to 
atherosclerosis [1].
The thrombocyte activation, which is triggered by major endothelial injury, 
creates main background for thrombus formation in the heart and arterial circula-
tion. However, the high rate of blood flow prevents thrombus and clot formation. 
Activation and adherence of platelets are major predisposing circumstance for 
thrombus formation beneath the high shear stress in arteries [2]. Arterial thrombi 
(defined as “white”) have been traditionally proposed to be composed mainly of 
fibrin and platelet aggregates. The Venous thrombi (defined as “red”) have been 
proposed as mostly being enriched in fibrin and erythrocytes [3].
The significant determinant for AT is the complex interaction of lipids, inflam-
mation and immune system, which is less, but, important for venous thrombosis as 
well [1]. The major mechanisms triggers intravascular thrombosis, lies at cellular 
and molecular levels, is known as “Virchow’s triad” and includes endothelial injury, 
stasis or turbulent blood flow and blood hypercoagulability. Endothelial injury 
leading to platelet activation almost inevitably underlies thrombus formation in the 
heart and the arterial circulation, where the high rates of blood flow impede clot 
formation. Platelet adherence and activation is a necessary prerequisite for throm-
bus formation under high shear stress, such as exists in arteries [4].
Abnormal blood flow contributes to AT by causing endothelial injury or dys-
function. Furthermore, chaotic blood flow forms countercurrents and local pockets 
of stasis. Stasis is major factor in the development of venous thrombi. Under condi-
tions of normal laminar blood flow all blood cells are found mainly in the center 
of the vessel lumen, separated from the endothelium by a slower moving layer of 
plasma, but static blood flow contributes to thrombosis. Hypercoagulability is  
high tendency of the blood to clot. It is an important risk factor for venous  
thrombosis [5].
Some peripheral blood biomarkers are useful preventive markers for arterial and 
venous thrombosis. The association of venous thrombosis and the ABO histo-blood 
group is well established. Numerous studies have demonstrated the association 
between the ABO blood system and venous thrombosis. It has already been fre-
quently revealed in various populations that venous thrombosis is less frequent in 
the O group than in individuals with other ABO blood groups. Individuals including 
A, B and AB (non-O) blood group have increased of venous thrombotic disease 
incidence compared to the O blood group individuals.
The non-OO blood group carriers are at more significant, two-fold risk of 
thrombosis rather than the individuals falling into the OO blood group carriers. 
Accordingly, the significant serious risk of thrombosis was higher in B alleles’ 
carriers than in those carrying A alleles [6]. Many scientific data showed the blood 
group’s possible protective effect with venous thrombosis [7].
Under an increased risk of venous thrombosis discussed, the ABO blood group 
influences plasma levels of the coagulation glycoprotein named von Willebrand 
factor (vWF). The vWF levels are 25% lower in the O group individuals compared 
to other blood groups. The mechanism of how the ABO group determines plasma 
vWF levels has not been clearly determined. It is already known that ABO (H) 
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carbohydrate antigenic determinants are expressed on the N-linked glycan chains of 
circulating plasma vWF [8].
As it already mentioned vWF is a risk factor as AT as VT. It is the molecular 
player in pathogenesis of thrombosis. The high level of vWF is correlated with 
arterial thrombosis, and especially morphological changes of vWF is a risk factor 
of cardiovascular disease, through promoting the platelet binding to damaged 
endothelium and platelet aggregation [9]. In the case of venous thrombosis, vWF is 
essential for flow reduction-induced thrombus formation in deep veins (Deep vein 
thrombosis (DVT)). The vWF-mediated platelet recruitment in DVT in the setting 
of blood flow disturbance plays an important pathogenic role. The gene mutations 
and polymorphisms, aging, hormone status, ABO blood groups, and systemic 
inflammation, have been involved in the modulation of both VTE predisposition 
and plasma levels of vWF [10].
Aging and ABO blood type influence in the bidirectional and combined way 
on vWF and FVIII levels. There are many studies shown that vWF significantly 
elevated in centenarians and type non-O individuals achieved much earlier in life 
the high vWF levels [11–13].
It has been investigated that the rate of venous thromboembolism is higher in 
black rather than white populations. Also, the non-O blood types have been associ-
ated with a notably high risk of venous thromboembolism. Since the majority of 
black population has an O blood and B blood type, thus may expect low cases of 
this disease. But it is paradoxical to find that VT prevalence has been observed to 
be higher in blacks than whites [14]. Due to the study to reveal suppose association 
between ABO and VT in blacks separately was, find out that the rate of VT was 
quite higher in non-O blood type individuals comparing to those with O blood 
groups, which also previously fixed in whites. Obtained data suggests that non-O 
blood type may consider as protective factor against VT in blacks too. The VT rate 
was higher in both, black and white non-O blood group individuals and was higher 
in males comparing to females and increasing with age. Further studies also con-
firmed above mentioned association with O group, that it may be a protective factor 
against VT, regardless of age and gender.
Various studies have also been reported similar to AT [15], while in different 
studies, this similarity was not found [6]. The study done in Switzerland reported 
that 2.5 times higher prevalence of B allele among MI patients than controls [16]. 
Underlined mechanism where may B allele is involved in pathogenesis of MI is still 
uncertain, since the role of ABH antigen is still unclear. In this regards various pos-
sibilities can be discussed.
The association between ABO histo-blood group, factor VIII and vWF have 
currently been revealed by O’Donnel and Laffan et al., [17] where BB homozygous 
had significantly high levels of vWF. The mechanism how B blood type affects 
vWF plasma levels is uncertain, but it is already defined that epitopes of N-linked 
oligosaccharide on the serum proteins modulate their half-lives. Hence it may be 
suggested that the ABH epitopes affect vWF plasma levels which cause elevation of 
vWF plasma levels, which is highly associated with increased risk of MI.
There are two major pathophysiological explanations tell that B antigen deter-
mines an aggregation of platelets, which may be a precursor of MI. The first mecha-
nism is that removal of B antigen from multimeric glycoprotein by α-galactosidase 
decreases ristocetin cofactor activity [18] and the second is the fact which is claim-
ing that increased platelet adhesiveness is shown in non O group individuals.
A study confirms the link between some vascular disorders and the non-O blood 
groups. The study has shown that there was a similar effect of ABO(H) on the level 
of vWF, but further research is required for obtaining more details on O(H) antigen 
expression levels in thrombosis. However, as A1A, A1B and BB composed of the 
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meaningful proportion of the population attributable fraction of VT, there may be 
a role for more widespread adoption of ABO(H) typing in testing strategies [19]. 
The study of the Iranian population has not shown a significant association between 
ABO blood groups and coronary artery diseases. Similar results have been shown 
in the cases of different blood groups as well [20]. Similar results were revealed 
according to the study of the cardiovascular risk factors and MI in the Turkish 
cohort. The study showed no difference according to the cardiovascular risk factors 
and different blood groups within patients with MI and healthy population [21]. No 
association of the blood group B with MI in the sample population in Malaysia has 
been revealed [22].
Our research aimed to find a possible relationship between the blood groups, 
such as ABO, Rh, Kell, MN and AT, based on the cases of the Georgian population. 
The cardiovascular system diseases are also topical for Georgia, which is proved 
by “The European Heart Network” (EHN) (based in Brussels, EHN is an alliance 
of different countries together with non-governmental organizations and “Heart 
Foundations”). According to the research conducted by the alliance, in 2015, 29.007 
deaths were reported in men and 33.509 in women ([European Cardiovascular 
Disease Statistics 2017 (http://www.ehnheart.org/cvd-statistics.html).
2. Research materials and methods
In our study, we aimed to determine blood group antigens in patients with AT. 
The study material consisted of blood samples of 100 patients with AT which were 
further processed according to the appropriate methodology.
The research materials were collected at the Heart Disease Department of 
Batumi Referral Hospital (Republic of Georgia). The research was implemented of 
the two years of 2019–2020. This work received financial support from the Batumi 
Shota Rustaveli State University (Grant project №02–12/57. 15.02.2019). Also, the 
control group was studied. The Control group included individuals without cardio-
vascular disease during the period from 2019 to 2020. They were asymptomatic, 
healthy persons. All participants in the control group were from the Adjara Region 
(Republic of Georgia). The age range of male and female individuals in both groups 
(patients and controls) was 40–93. All donors and patients gave their written 
informed consent for participation in this study, which has been duly approved 
by the Ethics Committee from the “UnimedAdjara” Ltd. (Adjara, Georgia).(Ethic 
approval number is BAH-15-1026-4/1 26.10.2015).
The express forward and reversed method with universal monoclonal antibod-
ies was applied in order to type blood groups and reveal the blood group system 
antigens. Anti-A, anti-B, anti-AB monoclonal antibodies were used for ABO blood 
group typing (Figure 1). Five monoclonal antibodies, anti-D; anti-C; anti-c; anti-E 
and anti-e were used to identify Rh system antigens. MN blood group phenotypes 
have been typed by two anti-M and anti-N antibodies and Kell system antigens 
were determined by anti-Kell and anti-k antibodies (Bio-Rad, cypress diagnostics) 
(Figure 2). Also, for research purposes, standard O(I), (II), (III) group erythro-
cytes and standard O(I), A(II), B(III), AB(IV) serums were used. For identifying 
erythrocyte blood group antigens ID cards such as ABO/D + Reverse Grouping 
(Bio-Rad) (Figure 3) were used. The Obtained material has been studied and 
processed statistically.
The results were processed with the bio statistical methods. The rates between 
donors and patients groups were compared by Chi-square analysis of proportions. 
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Figure 1. 
ABO blood group typing by monoclonal antibodies.
Figure 2. 
ABO, Rh, MN, Kell blood group typing.
Figure 3. 
ABO/D + Reverse Grouping ID card.
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The level of statistical significance was set at 0.05 in all analyses. The donors and 
patient cohort are the same profile. All participants have the same nationality. They 
are Georgians and age intervals are the same for both cohort.
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This test allows assessing the difference between observed (O) and expected (E) 
values. We used as on-variable chi-square as in some case two-variable chi-square 
criterion.
Gene distribution frequency of the ABO system in the studied cohorts was also 
analyzed. Their frequency was calculated using the formula used in the study of the 
three-allelic genetic system. Where O, A and B are the ration of people carrying 0 
(I), A (II) and B(III) groups to the total number of research objects.
 1; ;1r O p A O q B O= = − + = − +  
Alleles of the Kell and Rh system were also analyzed in the studied cohorts. 
Different frequencies of p(K), p(D) and q (k), q (d) were found in the target groups.




Where naa is a recessive homozygote according above mentioned locus (kk,dd), 
N is the total number of examined individuals.
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where An  means the number of carriers of the phenotype M, ABn  indicates MN 
phenotypes, Bn  means the number of carriers of the phenotype N.
3. Age, gender, smoking and arterial thrombosis
3.1 Age, gender and arterial thrombosis
As already well known, aging is considered a physiological process with the 
gradually ongoing accumulation of numerous structural alterations in cells, tissues, 
and organs. Accordingly, most alterations are associated with functional changes 
and have significantly increased susceptibility toward some diseases. There is an 
exponential increase in the risk of both arterial and venous thrombotic events 
with aging. This fact has been proven by several studies that revealed the increased 
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plasma concentration of V, VII, VIII, IX factors, fibrinogen as well as vWF levels 
which is increasing progressively along the age [12, 23]. In addition, it has revealed 
that high plasma levels of fibrinogen supposedly cause the high incidence of cardio-
vascular events in age [24].
The activity of proteolytic enzymes (PEs) in the blood serum changes with age 
[25]. Physiological aging also correlates with increased plasma levels of numerous 
blood coagulation proteins and fibrinolysis impairment. The studies confirm that 
there is an association between vascular and thromboembolic diseases and aging. 
Thus, the state of hypercoagulability tends to increase the risk for the development 
of thrombosis. Accordingly, hypercoagulability considers a significant marker 
associated with impairment in advanced age [26]. The blood coagulation capacity 
increases according to age in healthy individuals because of increases in the most 
procoagulant factors [27]. The blood coagulation potential a gradual increase 
during young adulthood and an almost 2-times elevated in old age [28]. The study 
confirmed that aged 53–64 years is associated with significantly higher fibrinogen 
levels than younger aged 20 [29]. The plasma concentration of several clotting 
factors increase with progressing age in healthy [30]. It suggests that thrombotic 
diseases are found more frequently in subjects with higher plasma levels of factor 
VII [26].
In the human body PEs have a significant role. PEs is responsible for numerous 
processes in health and disease. Moreover, PEs is considered a significant factor 
in several physiological processes, including morphogenesis, cell differentiation, 
etc. [31]. According to the physiological coagulation mechanism, the calcium and 
platelet together contain a PEs like the trypsin, which transforms prothrombin to 
thrombin [32]. Paczek et al. aimed to investigate the associations between the aging 
process and PEs activity (including trypsin, elastase, plasmin, and active MMP-9). 
As they found, the active MMP-9 concentration and trypsin activity decreased 
according to age. Notably α 1-antitrypsin concentration and plasmin activity are 
elevated. This study suggests that individual PEs activity in the serum changes with 
age [33].
We have studied 100 patients with AT. The materials have been taken randomly. 
The 77% of patients were males and the rest of 23% were females. 100 volunteers 
were used as the controls group in the study. All volunteers were healthy. Age interval 
was the same for donor cohort as well. The gender ratio was not equal in patients and 
donors. 51% males and 49% females were studied in our controls group (Table 1).
As our research has shown, the gender ratios between patients and controls are 
different. In this case, we used a two-variable chi-square criterion. Statistically 
revealed a high number of chi-square criteria for both variations. This data indi-
cates the relationships between qualitative variables. In this particular case, the 
value χ2 effectively rejects the null hypothesis (E = 0). The value of χ2 in the case 
of males is 64.32, and in the case of females equals to 39.94. These numbers are 
much higher than the critical value (CV) of the criterion of the degree of freedom 
(d.f. = 1), which is equal to 3,841. The P-Value is < .00001. The result is significant 
at p < .05 (Table 1).
Gender Patients Control χ2, (d.f.) = 1
Male 77 ± 4,2 51 ± 4,99 64,32 CV = 3,841
Female 23 ± 4,2 49 ± 4,99 39,94
Table 1. 
Gender ratio in donors and in the control group.
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In our study we have been allocated six age categories (Table 2) as well in 
patients as in control cohort. As it has presented on the table in young categories, 
age range between 40–49, there are not female patients, however from the alterna-
tive gender, 11 patients belongs to current age group. The majority of patients (56 
males and 20 females) are over the 60 years old.
As our data shows, AT is much more common in males than in females. Men 
have a higher risk of first and recurrent venous thrombosis than women. The 
pathophysiology of this phenomenon is yet unknown [34]. In the United States, 
cardiovascular diseases are the leading cause of death; for example, in 2013 death in 
both sexes were equal. However, several cardiovascular diseases occur early in age-
onset within men than women, like MI and coronary heart disease (CHD), where 
women’s prevalence is ~10-year delay in onset [35–37].
3.2 Smoking and arterial thrombosis
The harmful habits such as smoking, alcohol, drugs have a negative impact on 
human health. In particular, they have some implications to provoke diseases of  
the cardiovascular system. The cigarette smoke exposure (CSE) is known to 
increase the risk of AT. The almost 40% of smoking-related deaths are associated 
with cardiovascular disease. Both active and passive CSE predispose to  
cardiovascular events.
It is known that cigarette smoking increases inflammation, thrombosis, and 
oxidation of low-density lipoproteins (LDL). Several clinical and experimental data 
support that cigarette smoke increases the cell’s oxidative stress that can promote 
cardiovascular dysfunction [38]. In some studies are reported that acute CSE leads 
to functional changes in both fibrinogen and platelets, affecting clot dynamics, 
which were correlated with an alteration in fibrin structure [39].
We have analyzed the possible association between cigarette smoking and AT. 
Accordingly, three target groups were allocated: active smokers, non-smokers, and 
ex-smokers. 35% of patients were non-smokers, 39% were ex-smokers and 26% 
were active smokers (Table 3).
As it is shown from the table (Table 3), 35% of patients with arterial thrombosis 
had no exposure to tobacco use, while in the controls group nonsmoker are 1.7 times 
more (60%). Statistically revealed a high number of chi-square criteria, which 
indicates the relationships between qualitative variables. In this particular case, the 
value χ2 is quite effective for rejecting the null hypothesis (E = 0). The value of χ2 
in the case is 55, 05 These numbers are much higher than the critical value (CV) of 
№ Age category Patients Control
Male Female Male Female
1 40-49 11 0 6 3
2 50-59 10 3 6 7
3 60-69 25 4 16 20
4 70-79 23 11 17 11
5 80-89 7 4 6 6
6 90-99 1 1 0 2
n 77 23 51 49
Table 2. 
Age category and gender in donors and control group.
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the criterion of the degree of freedom (d.f. = 2), which is equal to 5,991. The result is 
significant at p < .05.
We have also been analyzed the age and gender groups of smokers, non-smokers 
and ex-smokers among patients with AT (Table 4). As it is shown on the table 
there are not female patients in the smokers’ (n = 26) category. All 26 active smoker 
patients are males. As we can see, the highest rates of AT is revealed in the category 
of smokers, in which only men between 60–69 years of age were observed, (12 indi-
viduals in total) and further more in the category of ex-smokers males dominates 
as well with the age of 70–79 (15 males and 1 female). Among whole research group 
39% of patients were ex-smokers.
It is a wonder why the number of ex-smokers exceeds to the active smokers in 
our research? We do not have sufficient information when and with what a reason 
ex-smoker patient group gave up smoking. The high prevalence of ex-smokers in 
patients may be due to the fact that they had to quit smoking due to deterioration 
their health condition. On the other side the ex-smokers have a greater experience 
of smoking (at least 10 years), they have accumulated more toxic substances in the 
body, atherosclerotic plaques, have abnormal fibrin structure and etc., which may 
also be one of the considerable reasons for high incidence.
4. Blood groups and arterial thrombosis
4.1 ABO blood group and arterial thrombosis
Many studies have found that blood group phenotypes play as an important 
genetic risk factor in many diseases. For example, in hemostasis, the ABO blood 
group has a great influence since it is a crucial determinant of the vWF and there-
fore, to coagulation factor VIII (FVIII). Besides, an individual with O blood group 
has around 25% lower vWF and FVIII circulating levels comparing to other blood 
group individuals. Some experimental studies show that several inflammatory 
Category Smokers Non-smoking Ex-smokers χ2 (d.f. = 2) CV
Patients 26 ± 4,38 35 ± 4,76 39 ± 4,85 55,05 5,991
Control 26 ± 4,38 60 ± 4,89 14 ± 3,46
Table 3. 
Smokers, non-smokers and ex-smoker among patients with arterial thrombosis and control.
Age Smokers (26) Non-smokers (35) Ex-smokers (39)
Male Female Male Female Male Female
40-49 8 0 0 0 3 0
50-59 2 0 3 2 4 1
60-69 12 0 2 4 11 0
70-79 3 0 6 10 15 1
80-89 1 0 3 4 3 0
90-99 0 0 0 1 1 0
Table 4. 
Smokers, non-smokers and ex-smokers among patients with arterial thrombosis (by age and sex).
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cytokines and cholesterol levels may be the most likely mechanisms to explain an 
association between ABO blood group and cardiovascular diseases [42–45].
Numerous studies have established an association between venous thrombo-
sis and the non-0 group. The mechanism of an association with the ABO blood 
group and cardiovascular disease has not been fully explored. However, there is a 
hypothesis that ABO glycosyltransferases modify glycoproteins and glycolipids on 
platelets’ surface effects on the platelet function. The antigens of the ABO system 
are not presented only on the erythrocyte surface; There are also founded on the 
cells of epithelium platelet and vascular endothelium, as well [46]. Thus, they are 
extending potential pathophysiology into other areas of cardiovascular disease and 
postoperative outcomes.
According to the authors, it is suggested that venous and arterial thrombotic 
disorders have different pathophysiological backgrounds; for example, arterial 
thrombosis has extended by platelet activation, while venous thrombosis is based 
on the clotting system activation [3].
Our study aimed to find an association between blood groups and arterial 
thrombosis. 100 patients with arterial thrombosis and the same number (100) 
healthy control group’s were investigated. In the control group, the distribution 
of ABO blood group phenotypes was as follows: group O – 48%; group A – 38%; 
group B –12%; and group AB – 2%. A similar distribution was revealed in the 
patients as well (Table 5). As the obtained data confirms, the correlation was not 
found between the ABO blood group and AT. The prevalence of ABO blood group 
phenotypes (O, A, B, AB) is the same in the patients and the controls. ABO system 
gene frequency is the same both cohort. The r allele frequency is 0,68, p – 0,08 and 
q – 0,23.
In this case, we have a Null hypothesis (E = 0). This means that there is no asso-
ciation between the two variables. The value of χ2 criteria is equal to 0,09, which 
is much less than the critical (CV) value of the degree of freedom (d.f. = 3), equal 
to 7,815. The P-Value is.029291. The result is significant at p < .05. Our result is the 
same as the study, including Iranian patients with coronary artery disease. The asso-
ciation with particular ABO blood groups was not found based on the comparison 
analysis between coronary artery disease general population [20]. The same data 
is in the study of risk factors and myocardial infarction (MI) in a Turkish cohort. 
The Turkish population study shows that ABO blood group antigens’ frequency was 
the same in the patients and the control group [21]. There is no association of blood 
group B with MI in the sample population in Malaysia [22].
4.2 Rh factor and arterial thrombosis
Our aim was also to find a possible correlation between Rh blood group antigens 
and AT. Next to the ABO system, the Rh blood group system is the second signifi-
cant human blood group system [47], which comprises 49 blood group antigens, 
among them the five D, C, c, E, and e antigens are the clinically most important 
Category O (I) A (II) B (III) AB (IV) ABO system Genes 
frequency
χ
2 (d.f. = 3) CV
r p q
Patients 47 ± 4,99 38 ± 4,83 13 ± 3,36 2 ± 1,4 0,69 0,08 0,23 0,09 7,815
Control 48 ± 4,99 3 8 ± 4,83 12 ± 3,24 2 ± 1,4
Table 5. 
ABO blood group phenotypes distribution among patients with AT and control.
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antigens. Rh blood group is associated with the hemolytic disease of the newborn. 
The hemolytic condition occurs when there is an incompatibility between the 
mother and the fetus’s Rh blood types.
The majority of the available studies involved ABO blood group and risk of 
cardiovascular diseases, while there is a lack of data on the Rh factor’s effect on MI’s 
risk and prognosis. Serum cholesterol varied significantly in the Rh system, but not 
in the AB0 system [48].
The Rh family proteins include none erythroid Rh homologs found on the 
epithelial tissues of different organs, such as kidney, liver, brain, and skin [49]. 
Some data points to the coincidence of certain cardiovascular risk factors with 
the Rh blood group [50]. It has been described that positive Rh is an independent 
risk factor for low levels of high-density lipoprotein (HDL) cholesterol, which is a 
well-known risk factor for cardiovascular disorders. Except for that, several clinical 
studies reported that the Rh genotype is correlated with systolic blood pressure [51].
Rh factor was studied in both patients and control cohort. 78 studied patients 
were Rh-positive and the remaining 22 were Rh-negative. The prevalence of the Rh 
phenotypes was similar in the control group (79 – Rh-positive and 21 - Rh-negative) 
(Table 6). Rh system gene frequency is the same for both cohorts. The frequency of 
q allele is 0,46, p allele – 0,54.
In our study, the prevalence of the Rh blood group phenotypes (Rh-negative 
and Rh-positive) is the same in the patients and the controls. Based on our study, 
we could not found any correlation between arterial thrombosis and Rh blood 
group because the Rh phenotypes in the controls and patients groups are equally 
distributed. We are not able to reject the Null hypothesis (E = 0). There is no reliable 
difference between the two categories. The value of χ2 criteria, in this case, is equal 
to 0.05, which is much less than the Critical Value (CV) of the degree of freedom 
(d.f. = 1), which is equal to 3,841. The P-Value is.025347. The result is significant at 
p < .05 (Table 6).
4.3 MN blood group and arterial thrombosis
The MNS antigen system is a human blood group system based upon two genes 
(glycophorin A and glycophorin B) on the 4th chromosome 4q28.2-q13.1. There are 
currently 46 antigens in the system [52], but the five most important are called M, 
N, S, s, and U. We have studied 2 antigens from this system. Based on this, we have 
allocated 3 phenotypes (M group, N group, and MN group) in the control cohort 
and the patients. There is little information about MN blood group correlation with 
some kind of infectious disease [53, 54].
No information could have been obtained through the scientific literature about 
the correlation between MN blood groups and AT. But there are some informa-
tion about association of MN blood group and hypertension. Males with the 
MN phenotype had significantly higher unadjusted systolic and diastolic blood 
pressures than those who were homozygous MM or NN [55]. The increased of 




Patients 78 22 0,46 0,54 0,05 3,841
Control 79 21
Table 6. 
Distribution of Rh positive and Rh-negative blood group in patients and control.
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erythrocyte sodium-lithium counter-transport activity associated with hyperten-
sion. Erythrocyte sodium-lithium counter-transport genetically is heritable, but 
it is not monogenic inheritance [56]. It is complex genetically characteristics. 
Some authors studied the association of blood pressure, sodium-lithium counter-
transport and two genetic markers – MN Blood group system and haptoglobin in 
Michigan population example. They find genetic linkage between the MN locus and 
red blood cell sodium-lithium counter-transport activity. The authors suggested 
that the relation between MN phenotype and systolic blood pressure is different in 
men and women. The men with the MN phenotype and having high systolic blood 
pressure had significantly elevated red blood cell sodium-lithium counter-transport 
activity [57].
Delanghe et al., study suggested that detection age of hypertension was lower 
for patients with MN phenotype. The increasing age of detection the distribution of 
MN phenotype gradually decreases. The hypertensive with MM blood group had a 
lower prevalence of cerebrovascular accidents [58].
Sobha R. et al., found that the distribution of MN blood groups differs signifi-
cantly in asthma patients and controls (chi-square - 15.1160, d.f. 2, Pp > .2) suggest-
ing that blood group MM is resistant to asthma. The comparison of NN blood type 
reveals non-significant differences between asthma patients and controls [59].
In our studies the prevalence of MN blood group phenotypes was not equal in 
controls and patients groups (Table 7). The frequency of M+ N+ (MN) phenotype 
was relatively high in the patient groups compared to the controls. 43/100 patients 
and 30/100 donors carry the M+ N+ (MN) phenotype. In contrast, the major part of 
the control group (n = 55) had M+ N- (MM) phenotype, which is 1,14 times higher 
than in the patients’ group (n = 48). The study also has revealed the differences 
according to the prevalence of the M-N+ (NN) phenotype control and patients’ 
groups. The nine patients had the M-N+ phenotype characteristics, which is 1,8 
times less than in the donors (n = 15). The study of MN system alleles frequency do 
not show any significant differences between to cohorts (Table 7).
The χ2 criteria is 8,95, which is only 3 units higher then CV (d.f. = 3). In this 
case, the chi-square criterion indicates the existence of relationship between the 
two qualitative variables and the rejection of the null hypothesis (E = 0). The 
P-Value is < .00001. The result is significant at p < .05 (Table 7).
4.4 Kell blood group system and arterial thrombosis
The Kell blood group system is a complex and contains many highly immuno-
genic antigens. The locus of Kell blood group system is highly polymorphic and 
gives rise to many Kell antigens in human being. The Kell system gene locus is 
found on chromosome 7, at 7q33 and contains 19 exons. This locus encoding the 25 
antigens and majority of Kell blood group system antigens are glycoproteins. Some 
of them are highly immunogenic. The Kell antigen is expresses only by erythroid 
progenitor cells and mature erythroid cells. There are two codominant allelic genes 
that produce two main antigens: Kell (K) and Cellano (k). These antigens differ to 
Category M+N+ M+N- M-N+ MN allele frequency χ2, (d.f. = 2) CV
q P
Patients 43 48 9 0,695 0,305 8,95 5,991
Control 30 55 15 0,7 0,3
Table 7. 
MN group system phenotype frequency in patients and control group.
13
The Study of Some Possible Risk Factors for Arterial Thrombosis in the Example of Georgian…
DOI: http://dx.doi.org/10.5772/intechopen.96121
each other by a single amino acid. The prevalence of these antigens is not same. The 
k antigen is more common in most world population. K–K+ phenotype is found 
in 98% of Blacks and 91% of Caucasians. These antigens are the third most potent 
antigens after ABO and Rh blood groups, triggering an immune reaction [60].
Kell blood group system is important not only transfusion but also clinically 
is associated with the Hemolytic Disease of the Newborn (HDN). HDN caused 
by anti-Kell1 antibody is the second most common after Rh disease. Anti-Kell is 
becoming relatively more important as the prevention of Rh disease is also becom-
ing more effective.
Unlikely to Rhesus and ABO immunosensibilization, HDN attributable to 
Kell sensitization is causes by anti-K antibody suppressing the fetal red blood cell 
(RBCs) production. The main reason of this is well known. The Kell antigens gener-
ally expressed on the surface of RBCs precursors, and anti-K antibodies initiated 
immune destruction of K positive elytroid precursor cells by macrophages in the 
fetal liver. The RBCs progenitor cells do not contain hemoglobin. There is releasing 
less amount of bilirubin and newborn very rarely presents a jaundice phenotype of 
anemia [61].
We could not have obtained any information about the correlation between 
the Kell blood group antigens and cardiovascular disease. The study according to 
the Kell system 2 phenotypical groups (K+ and K- phenotypes), showed that the 
frequency of K+ phenotype (KK or Kk) is a high in the patients compared to the 
controls. 87 of the studied control have the K-negative (kk) phenotype, and as 
for the patients with arterial thrombosis, the prevalence of the above-mentioned 
phenotype is 79. The Kell antigen prevalence was relatively high in the studied 
patients (n = 21) and 13 healthy control were carriers of Kell antigen. K+ phenotype 
characteristics are highly prevalent in patients than in donors. Kell system alleles 
frequency are not same between to cohort (Table 8). In this case, quite a high num-
ber of χ2 criteria was observed, which indicates the relationship between qualitative 
variables. χ2 value is equal to 51,73. Which is much more than CV (3,841) of df  
(d.f. = 1). The P-Value is < .00001. The result is significant at < .05 (Table 8).
5. Conclusion
Thus, our study has shown maleness as a higher risk factor for AT. The study 
also revealed that smokers have a more predicted chance for AT compared to non-
smokers. K+ phenotype and M+ N+ characteristics are of the high prevalence in 
the patients than in the donors. The correlations of the Kell and MN blood groups 
with AT have practical significance. There is no correlation between the ABO and 
Rh blood groups with AT based on our research; however, we think that finding 
the possible association needs to be identified with multicenter, prospective, and 
large-scale studies. Based on our research, it is possible to single out high-risk 
groups of disease and implement preventive arrangements on the individuals of 
these groups.
Category k Kell Kell system alleles frequency χ2, (d.f. = 1) CV
q p
Patients 79 21 0,88 0,12 51,73 3,841
Control 87 13 0.93 0,07
Table 8. 
Kell and k phenotype frequency in patients and control group.
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